Viro Lec - Part 1 Module 3 - Last part Flashcards

1
Q

Activates the signaling cascade → resulting to induction of the interferon response genes in cells

A

Type 1 interferon (IFN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cytokine central to both innate and adaptive immunity

A

Type II interferon or IFN-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Example of PAMPS

A
  1. Nucleic acids (viruses)
  2. Surface lipoprotein (viruses)
  3. Lipoprotein (bacteria)
  4. Capsule (bacteria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Binding of PAMPs to PRRs stimulates?

A

transcription of numerous genes encoding proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

class of PRRs

A

Toll-like receptors (TLRs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

TLRs bind ssRNA, detect RNA virus infections

A

TLR7 & TLR8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TLRs detects dsRNA

A

TLR3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Specialized lymphocytes; Lack an antigen-specific receptor (but can recognize PAMPS)

A

Natural Killer Cells (NK cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Increased MHC1 means?

A

will indicate a not stressed cell → The NK cell will detect → NK will initiate inhibitory signal → therefore no apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Decreased MHC 1 means?

A

→ will indicate an infected/ stressed cell → NK will detect it → it will make the cell undergo apoptosis → the cell will die → therefore there is no replication and it will eliminate the virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NK cells have two types of receptors

A

○ Activating receptors (detect stress signals).
○ Inhibiting receptors (detect normal proteins like MHC molecules).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NK cells release granules containing:

A

Perforin & Granzymes (A & B):

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Forms pores in the target cell membrane.

A

Perforin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Enter through the pores to trigger cell death.

A

Granzymes (A & B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mediated by antibodies secreted by terminally differentiated lymphocytes called plasma cells

A

Humoral immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

driven by cell receptors expressing lymphocytes

A

Cell-mediated immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when activated by infected cell, it will produce cytokines

A

T- Helper Cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

will directly and cause apoptosis of infected cell

A

Cytotoxic T Lymphocytes

19
Q

Processes antigens from intracellular sources

A

Class I MHC Pathway (Cytosolic Pathway)

20
Q

Processes antigens from extracellular sources

A

Class II MHC Pathway (Endocytic Pathway)

21
Q

Cytosolic Pathway is recognized by?

A

CD8+ Cytotoxic T cells

22
Q

Endocytic Pathway is recognized by?

A

CD4+ Helper T cells

23
Q

Antibody found primarily in blood; first antibodies produced

24
Q

Antibody principal class of Ab in blood and extracellular fluid

25
Antibody main antibody in secretions in respiratory, genital and GIT
IgA
26
Antibody very low conc. in blood and ECF; mediates allergic reactions
IgE
27
Antibody expressed almost exclusively as a cell surface molecule by naïve B cells
IgD
28
Types of Vaccines
● Live-attenuated virus vaccines ● Non-replicating virus vaccines ● Vaccines Produced Using Recombinant DNA and Related Technologies
29
Vaccines that elicits a lasting immune response while causing little or no disease; mimics a subclinical infection
Live-attenuated virus vaccines
30
Vaccines usually made from virulent viruses that are killed through chemical or physical agents but still maintain immunogenicity
Inactivated (Killed) Whole Virions
31
Vaccines that use lipid solvents (e.g. sodium deoxycholate) in enveloped viruses to solubilize the virion and release the components
Purified Native Viral Proteins
32
Deliberate insertion of several attenuating mutations into key viral genes or completely deleting nonessential genes that contribute to virulence
Attenuation of Viruses by Gene Deletion or Site-Directed Mutagenesis
33
Utilizes eukaryotic expression vectors such as plant and yeast cells, insect cells and various mammalian cells
Subunit vaccines produced by expression of viral proteins
34
Some nonenveloped icosahedral viruses have capsid proteins that self- assemble into virus-like particles (VLPs)
Viral Proteins that Self-Assemble into virus-like particles (VLPs)
35
Recombinant DNA techniques enable the insertion of foreign genes into viral genomes.
Viruses as vectors for Expression of Heterologous Viral Antigens
36
A type of vaccine that uses a bacterial plasmid to introduce DNA sequence (encoding an antigen) into an individual’s cells
DNA vaccines
37
measures only one limb of the adaptive immune response which is the humoral immunity
(Serological Diagnosis)
38
sample of choice for serological assays
serum
39
assays of choice for the qualitative or quantitative determination of viral antibodies; rapid, relatively cost-effective
Enzyme Immunoassay – Enzyme-linked Immunosorbent Assay (ELISA)
40
the gold standard for the detection and quantitation of virus-specific antibodies; the binding of antibody to infectious virus, thus preventing the virus from initiating an infection in a susceptible cell
Serum (Virus) Neutralization Assay
41
simultaneously but independently measure antibodies against several proteins of the agent of interest
Immunoblotting (Western blotting)
42
widely used for viruses (e.g. influenza, parainfluenza) that hemagglutinate red blood cells of one or another species
Hemagglutination-Inhibition Assay
43